AT-101 induces apoptosis in CLL B cells and overcomes stromal cell–mediated Mcl-1 induction and drug resistance
Kumudha Balakrishnan(The University of Texas MD Anderson Cancer Center), Varsha Gandhi(The University of Texas MD Anderson Cancer Center)
Cited by 147
Related Papers
Ibrutinib and Venetoclax for First-Line Treatment of CLL
|New England Journal of Medicine|2019|502
Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia
|Blood|2011|161
B-cell Receptor Signaling Regulates Metabolism in Chronic Lymphocytic Leukemia
|Molecular Cancer Research|2017|50
Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines
|Journal of Hematology & Oncology|2013|22